Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Aug 1;56(8):480-485.
doi: 10.1097/RLI.0000000000000765.

Finding the Optimal Alternative for Immediate Hypersensitivity to Low-Osmolar Iodinated Contrast

Kyoung-Hee Sohn, Jang-Ho Seo, Dong-Yoon Kang  1 , Suh-Young Lee, Hye-Ryun Kang
Affiliations

Finding the Optimal Alternative for Immediate Hypersensitivity to Low-Osmolar Iodinated Contrast

Kyoung-Hee Sohn et al. Invest Radiol. .

Abstract

Objectives: Avoiding culprit agents is recommended for subjects who have had previous hypersensitivity reaction (HSR) to low-osmolar contrast media (LOCM). However, the guidelines for choosing optimal alternatives have not been determined. We investigated the outcomes of reexposure in patients with previous immediate HSRs to provide a safe option.

Materials and methods: The outcomes of reexposure were assessed in a cohort with previous LOCM-associated HSR based on skin testing results and the presence of a common N-(2,3-dihydroxypropyl) carbamoyl side chain.

Results: Among 482 skin tests, 38.7% (31/80), 45.8% (99/216), and 64.0% (119/186) of mild, moderate, and severe index HSRs showed positivity to at least 1 LOCM, of which 62.8% showed positivity to at least 2 different LOCM. The overall recurrent HSRs were reduced from 43.8% upon reexposure to the culprit LOCM to 12.3% upon using nonculprit skin test negative LOCM (P = 0.004); those with severe index HSRs exhibited a significant reduction (11.3% vs 100%), but those with non-severe HSRs to LOCM did not. In subjects with severe index HSRs, the skin test cross-reactivity between LOCM was associated with sharing the common side chain (20.7% vs 11.5%, P = 0.003), and the recurrence rate of HSRs was effectively reduced by avoiding the common side chain (24.0% vs 7.8%, P = 0.039). However, these differences were not observed in those with non-severe index HSRs.

Conclusions: In patients who experienced a severe index HSR to LOCM, skin test negative LOCM without a common side chain could be suggested as an option for safe reexposure.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest and sources of funding: none declared.

References

    1. Imran S, Eric L, Pierre D. Future of diagnostic computed tomography: an update on physicochemical properties, safety, and development of x-ray contrast media. Invest Radiol . 2020;55:598–600.
    1. Brockow K, Ring J. Classification and pathophysiology of radiocontrast media hypersensitivity. Chem Immunol Allergy . 2010;95:157–169.
    1. Lee SY, Yang MS, Choi YH, et al. Stratified premedication strategy for the prevention of contrast media hypersensitivity in high-risk patients. Ann Allergy Asthma Immunol . 2017;118:339–344. e1.
    1. Clement O, Dewachter P, Mouton-Faivre C, et al. Immediate hypersensitivity to contrast agents: the French 5-year CIRTACI study. EClinicalMedicine . 2018;1:51–61.
    1. Schopp JG, Iyer RS, Wang CL, et al. Allergic reactions to iodinated contrast media: premedication considerations for patients at risk. Emerg Radiol . 2013;20:299–306.

Publication types

LinkOut - more resources